GFPC
BSX icon

Global Financial Private Client’s Boston Scientific BSX Stock Holding History

Global Financial Private Client’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-361
Closed -$36.4K – 409
2025
Q1 		$36.4K Buy
361
+32
+10% +$3.22K 0.01% 374
2024
Q4 		$29.4K Buy
329
+11
+3% +$968 0.01% 375
2024
Q3 		$26.6K Buy
318
+118
+59% +$9.3K 0.01% 390
2024
Q2 		$15.4K Hold
200
– – 0.01% 406
2024
Q1 		$13.6K Hold
200
– – 0.01% 430
2023
Q4 		$11.6K Hold
200
– – 0.01% 442
2023
Q3 		$10.6K Sell
200
-4,813
-96% -$252K 0.01% 432
2023
Q2 		$268K Buy
5,013
+721
+17% +$37.7K 0.13% 153
2023
Q1 		$213K Buy
4,292
+4,092
+2,046% +$193K 0.11% 152
2022
Q4 		$9.25K Buy
+200
New +$8.66K 0.01% 434

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Global Financial Private Client's BSX Position: Q2 2025 in Review

Global Financial Private Client sold out of Boston Scientific (BSX) in Q2 2025, closing a stake of 361 shares — an estimated $36.4K sold.

Global Financial Private Client first reported a position in BSX in Q4 2022 and held it in 10 quarters. The position peaked at $268K in Q2 2023. 1,687 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

  • Global Financial Private Client reported no remaining Boston Scientific position as of Q2 2025 after selling out during the quarter.
  • Global Financial Private Client sold 361 Boston Scientific shares in Q2 2025, an estimated $36.4K.
  • Global Financial Private Client first reported a position in Boston Scientific in Q4 2022 and held it in 10 quarters.
  • Global Financial Private Client's Boston Scientific position peaked at $268K in Q2 2023.
  • 1,687 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Global Financial Private Client's 13F filing for Q2 2025, filed 10 Jul 2025.